Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.3140
-0.0215 (-6.41%)
At close: Feb 3, 2026, 4:00 PM EST
0.3135
-0.0005 (-0.16%)
After-hours: Feb 3, 2026, 7:37 PM EST
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $16.59 million as of February 3, 2026. Its market cap has decreased by -60.85% in one year.
Market Cap
16.59M
Enterprise Value
39.32M
1-Year Change
-60.85%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $16.59M, a decrease of -90.75%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 16.59M | -6.27% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Klotho Neurosciences | 18.89M |
| Lexaria Bioscience | 18.45M |
| FibroBiologics | 18.19M |
| Lunai Bioworks | 16.40M |
| Traws Pharma | 16.14M |
| Quantum BioPharma | 16.01M |
| Citius Pharmaceuticals | 15.93M |
| Applied Therapeutics | 15.70M |